BeiGene proposes new name, reaffirming oncology mission
By Catherine Eckford (European Pharmaceutical Review)
BioNTech oncology acquisition to advance bispecific antibodies
By Catherine Eckford (European Pharmaceutical Review)
New $3.5b AstraZeneca investment to accelerate US R&D and manufacturing
By Catherine Eckford (European Pharmaceutical Review)
Innovative static culturing method developed
By Catherine Eckford (European Pharmaceutical Review)
Life sciences response to 2024 Autumn Budget
By Catherine Eckford (European Pharmaceutical Review)
Future of oral small molecule drugs – addressing potential in…
By Andreas Muehler (Immunic Therapeutics), Daniel Vitt (Immunic Therapeutics)